24-norUrsodeoxycholic Acid Is Superior to Ursodeoxycholic Acid in the Treatment of Sclerosing Cholangitis in Mdr2 (Abcb4) Knockout Mice
Top Cited Papers
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 130 (2), 465-481
- https://doi.org/10.1053/j.gastro.2005.10.018
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Novel biotransformation and physiological properties of norursodeoxycholic acid in humans†‡Hepatology, 2005
- Oncosis represents the main type of cell death in mouse models of cholestasisJournal of Hepatology, 2004
- Reduced oncotic necrosis in fas receptor-deficient C57BL/6J- lpr mice after bile duct ligationHepatology, 2004
- NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 2004
- Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Neutrophils Aggravate Acute Liver Injury During Obstructive Cholestasis in Bile Duct-Ligated MiceHepatology, 2003
- Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)Biochemical Journal, 2003
- Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein geneGastroenterology, 1996
- Prevention of Ursodeoxycholate Hepatotoxicity in the Rabbit by Conjugation With N –Methyl Amino AcidsHepatology, 1990
- Effect of side chain length on bile acid conjugation: Glucuronidation, sulfation and coenzyme a formation of nor-bile acids and their natural C24 homologs by human and rat liver fractionsHepatology, 1988